Christopher Yoo

6PUBLICATIONS
41CO-AUTHORS
Metabolomic chemistryPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 30, 2026
Enhanced cfDNA methylation profiling by detection and correction of jagged ends.

|Sep 10, 2021
Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.

Everett J Moding, Yufei Liu, Barzin Y Nabet

|Feb 24, 2021
Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy.

Michael S Binkley, Susan M Hiniker, Sheren Younes

|Oct 19, 2020
KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition.

Michael S Binkley, Young-Jun Jeon, Monica Nesselbush

|Apr 10, 2020
Integrating genomic features for non-invasive early lung cancer detection.

Jacob J Chabon, Emily G Hamilton, David M Kurtz

|Feb 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.

Matthew D Hellmann, Barzin Y Nabet, Hira Rizvi

Pageof 1

Frequent Collaborators

4 joint publications

Barzin Y Nabet

4 joint publications

Maximilian Diehn

4 joint publications

Ryan B Ko

4 joint publications

Ash A Alizadeh